Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Ginger (Zingiber Officinale) on Glycemic Markers in Patients With Type 2 Diabetes Publisher Pubmed



Shidfar F1 ; Rajab A2 ; Rahideh T1 ; Khandouzi N3 ; Hosseini S4 ; Shidfar S5
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Health, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Iranian Diabetes Association, Tehran, Iran
  3. 3. Department of Nutrition and Biochemistry, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Chemistry, Robat Karim Branch, Islamic Azad University, Robat Karim, Iran
  5. 5. Worcester Memorial Hospital, University of Massachusetts, Worcester, United States

Source: Journal of Complementary and Integrative Medicine Published:2015


Abstract

Background: Ginger (Zingiber officinale) is one of the functional foods which contains biological compounds including gingerol, shogaol, paradol and zingerone. Ginger has been proposed to have anti-cancer, anti-thrombotic, anti-inflammatory, anti-arthritic, hypolipidemic and analgesic properties. Here, we report the effect of ginger supplementation on glycemic indices in Iranian patients with type 2 diabetes. Methods: A double-blind, placebo-controlled, randomized clinical trial was conducted on 20-60 -year-old patients with type 2 diabetes who did not receive insulin. Participants in the intervention and control groups were received 3 g of powdered ginger or placebo (lactose) (in capsules) daily for 3 months. Glycemic indices, total antioxidant capacity (TAC), malondialdehyde (MDA), C-reactive protein (CRP), serum paraoxonase, dietary intake and physical activity were measured at the beginning and end of the study, and after 12 h fasting. Results: Comparison of the indices after 3 months showed that the differences between the ginger and placebo groups were statistically significant as follows: serum glucose (-19.41±18.83 vs. 1.63±4.28 mg/dL, p<0.001), HbA1c percentage (-0.77±0.88 vs. 0.02±0.16, p<0.001), insulin (-1.46±1.7 vs. 0.09±0.34 μIU/mL, p<0.001), insulin resistance (-16.38±19.2 vs. 0.68±2.7, p<0.001), high-sensitive CRP (-2.78±4.07 vs. 0.2±0.77 mg/L, p<0.001), paraoxonase-1 (PON-1) (22.04±24.53 vs. 1.71±2.72 U/L, p<0.006), TAC (0.78±0.71 vs. -0.04±0.29 μIU/mL, p<0.01) and MDA (-0.85±1.08 vs. 0.06±0.08 μmol/L, p<0.001) were significantly different. Conclusions: This report shows that the 3 months supplementation of ginger improved glycemic indices, TAC and PON-1 activity in patients with type 2 diabetes. © 2015 by De Gruyter 2015.
Related Docs
View other Related Docs
1. The Effects of Ginger on Fasting Blood Sugar, Hemoglobin A1c, Apolipoprotein B, Apolipoprotein A-I and Malondialdehyde in Type 2 Diabetic Patients, Iranian Journal of Pharmaceutical Research (2015)
2. Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study, Hepatitis Monthly (2016)
3. Effects of Ginger on Serum Glucose, Advanced Glycation End Products, and Inflammation in Peritoneal Dialysis Patients, Nutrition (2015)
4. Effects of Ginger Supplementation on Anthropometric, Glycemic and Metabolic Parameters in Subjects With Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study, Journal of Diabetes and Metabolic Disorders (2019)
5. The Effects of Ginger on Fasting Blood Sugar, Hemoglobin A1c, and Lipid Profiles in Patients With Type 2 Diabetes, International Journal of Endocrinology and Metabolism (2017)
6. Does Ginger Supplementation Lower Blood Pressure? a Systematic Review and Meta-Analysis of Clinical Trials, Phytotherapy Research (2019)
7. Effect of Ginger on the Blood Glucose Level of Women With Gestational Diabetes Mellitus (Gdm) With Impaired Glucose Tolerance Test (Gtt): A Randomized Doubleblind Placebo-Controlled Trial, BMC Complementary Medicine and Therapies (2020)
8. Ginger Intervention on Body Weight and Body Composition in Adults: A Grade-Assessed Systematic Review and Dose-Response Meta-Analysis of 27 Randomized Controlled Trials, Nutrition Reviews (2024)
Experts (# of related papers)
View all Related Experts
Hossein Imani (2)
Ahmad Saedi Someolia (2)
Other Related Docs
9. Effects of Ginger on Serum Lipids and Lipoproteins in Peritoneal Dialysis Patients: A Randomized Controlled Trial, Peritoneal Dialysis International (2016)
10. Ginger: A Complementary Approach for Management of Cardiovascular Diseases, BioFactors (2021)
11. Effect of Ginger (Zingiber Officinale) on Blood Glucose and Lipid Concentrations in Diabetic and Hyperlipidemic Subjects: A Meta-Analysis of Randomized Controlled Trials, Journal of Functional Foods (2017)
12. Ginger From Ancient Times to the New Outlook, Jundishapur Journal of Natural Pharmaceutical Products (2015)
13. The Effect of Ginger Supplementation on Il2, Tnfα, and Il1β Cytokines Gene Expression Levels in Patients With Active Rheumatoid Arthritis: A Randomized Controlled Trial, Medical Journal of the Islamic Republic of Iran (2019)
14. Dietary Regulation of Mir-33B and Mir-29A in Relationship to Metabolic Biomarkers of Glucose and Lipids in Obese Diabetic Women: A Randomized Clinical Controlled Study, Iranian Red Crescent Medical Journal (2017)
15. Ginger for Prevention of Antituberculosis-Induced Gastrointestinal Adverse Reactions Including Hepatotoxicity: A Randomized Pilot Clinical Trial, Phytotherapy Research (2016)
16. Mechanisms of Action of Ginger in Nuclear Factor-Kappab Signaling Pathways in Diabetes, Journal of Herbal Medicine (2019)